In definitive radiotherapy, reducing the elective dose from 50 Gy to 43 Gy was safe and did not significantly increase the risk for recurrence in electively irradiated lymph nodes among patients with ...
Lisbeth Cordero Méndez, IAEA Department of Nuclear Sciences and Applications Research involving 23 countries has highlighted the safety and benefit of using artificial intelligence for a key and often ...
Palliative radiotherapy is an established modality aimed at alleviating symptoms and improving quality of life in patients with locally advanced or metastatic head and neck cancer who are unsuitable ...
In patients with extramedullary plasmacytoma of the head and neck, radiotherapy and surgery provide comparable survival outcomes, but radiotherapy significantly reduced the risk for progression to ...
ART’s potential to improve outcomes and quality of life is especially relevant in India, where head and neck cancers account ...